Skip to main content
Home
Latest news
Browse topics
Cardiovascular disorders Chronic kidney disease Diabetes devices & technology GLP-1 receptor agonists Hyperglycemia Hypoglycemia Obesity, diet, & lifestyle interventions SGLT2 inhibitors Type 1 diabetes Type 2 diabetes Browse all topics
EN
EN
In focus
Novel clinical evidence in continuous glucose monitoring Fasting for religion and health in people with diabetes The challenge of type 2 diabetes in children HFpEF & diabetes: Diagnosis and management in the wake of EMPEROR-Preserved Addressing suicide risk in diabetes: Rates and risk factors, HCP fears, and practical advice The SURPASS trials: Summarizing efficacy data on tirzepatide Semaglutide for weight loss: STEP and SELECT trials: Results from the STEP and SELECT trials Why psychosocial care matters DiRECT: Type 2 diabetes remission through weight management
Congress coverage
EASD 58th Annual Meeting 2022 The American Diabetes Association 82nd Scientific Sessions
About us
Medicine Matters Diabetes
EXTENDED SEARCH
13 search results for:

ESC 2021 

sort by |
"newest" sorts results by publication date. "most relevant" also considers factors like how often the search phrase is in the result.
  1. 08-28-2021 | ESC 2021 | News | Article

    FIGARO-DKD: Finerenone cardioprotective across broad range of renal risk

    Finerenone protects against adverse cardiovascular outcomes in people with type 2 diabetes and mild or moderate chronic kidney disease, the FIGARO-DKD investigators have reported at the virtual ESC Congress 2021.

    Author:
    Eleanor McDermid
    Published in:
    N Engl J Med 2021; doi:10.1056/NEJMoa2110956
  2. 09-01-2021 | ESC 2021 | News | Article
    News in brief

    ‘Exceedingly high’ vascular event risk with type 2 diabetes plus PAD

    And having type 2 diabetes was associated with an additional 58% increase in risk. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group ESC Congress 2021: 27–30 August

    Author:
    Eleanor McDermid
    Published in:
    ESC Congress 2021: 27–30 August
  3. 08-27-2021 | ESC 2021 | News | Article

    EMPEROR-Preserved: A win for empagliflozin in HFpEF

    Presenting the findings to press attendees at the virtual ESC Congress 2021 , Stefan Anker (Charité Universitätsmedizin Berlin, Germany) showed the topline results of HFpEF trials dating back to 2003.

    Author:
    Eleanor McDermid
    Published in:
    N Engl J Med 2021; doi:10.1056/NEJMoa2107038 N Engl J Med 2021; doi:10.1056/NEJMc2112411 N Engl J Med 2021; doi:10.1056/NEJMe2113008
  4. 08-27-2021 | ESC 2021 | News | Article

    Dapagliflozin may reduce risk for ventricular arrhythmias, sudden death

    The publication of these findings coincided with their presentation at the virtual ESC Congress 2021 . medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group Eur Heart J 2021; doi:10.1093/eurheartj/ehab560 Eur Heart J 2021; doi:10.1093/eurheartj/ehab563

    Author:
    Eleanor McDermid
    Published in:
    Eur Heart J 2021; doi:10.1093/eurheartj/ehab560 Eur Heart J 2021; doi:10.1093/eurheartj/ehab563
  5. 08-26-2021 | ESC 2021 | News | Article

    Canagliflozin may protect against hyperkalemia in type 2 diabetes with CKD

    The study data were also presented as an eposter at the virtual ESC Congress 2021. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group Eur Heart J 2021; doi:10.1093/eurheartj/ehab497 Eur Heart J 2021; doi:10.1093/eurheartj/ehab561

    Author:
    Laura Cowen
    Published in:
    Eur Heart J 2021; doi:10.1093/eurheartj/ehab497 Eur Heart J 2021; doi:10.1093/eurheartj/ehab561
  6. play
    09-15-2021 | ESC 2021 | Conference coverage | Video

    FIGARO: Where will finerenone fit into diabetic kidney disease treatment?

    ESC 2021 video: David Wheeler talks about the findings of the FIGARO trial, the use of finerenone in people with type 2 diabetes, and how this may

  7. 08-27-2021 | ESC 2021 | News | Article

    Dapagliflozin benefits wide range of people with CKD

    The study data are published in JACC: Heart Failure and were also presented as an eposter at the virtual ESC Congress 2021. medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group JACC Heart Fail 2021; doi:10.1016/j.jchf.2021.06.017

    Author:
    Laura Cowen
    Published in:
    JACC Heart Fail 2021; doi:10.1016/j.jchf.2021.06.017
  8. 08-29-2021 | ESC 2021 | News | Article

    Metformin use may not influence SGLT2 inhibitor effect

    Both analyses were reported at the virtual ESC Congress 2021.

    Author:
    Eleanor McDermid
    Published in:
    ESC Congress 2021: 27–30 August
  9. 08-29-2021 | ESC 2021 | News | Article

    HF and CKD doubly dangerous for people with type 2 diabetes

    Presenting the findings at the virtual ESC Congress 2021, Aldo Maggioni (ANMCO Research Center, Florence, Italy) reported that HF was the most common cause of hospitalization even among people with CKD alone.

    Author:
    Eleanor McDermid
    Published in:
    ESC Congress 2021: 27–30 August
  10. 08-29-2021 | ESC 2021 | News | Article

    Empagliflozin has broad beneficial effect on HFpEF outcomes

    The findings were also presented at the virtual ESC Congress 2021 . medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group Circulation 2021; doi:10.1161/CIRCULATIONAHA.121.056824

    Author:
    Eleanor McDermid
    Published in:
    Circulation 2021; doi:10.1161/CIRCULATIONAHA.121.056824
  11. play
    08-29-2021 | ESC 2021 | Conference coverage | Video

    EMPEROR-Preserved: The implications for primary care

    ESC 2021 video: Kevin Fernando outlines the likely impact of the EMPEROR-Preserved findings for primary care practitioners treating people with type

  12. play
    08-29-2021 | ESC 2021 | Conference coverage | Video

    EMPEROR-Preserved: Diabetes medication becomes first effective HFpEF therapy

    ESC 2021 video: EMPEROR-Preserved: Diabetes medication becomes first effective HFpEF therapy.

  13. 04-08-2021 | Stroke | News | Article
    News in brief

    Genetic analysis backs causal link between blood glucose and stroke

    “Inclusion of ischaemic stroke in guidelines on treatment of diabetes and elevated plasma glucose may improve quality of patient diagnosis and care.” medwireNews is an independent medical news service provided by Springer Healthcare Ltd. © 2021 Springer Healthcare Ltd, part of the Springer Nature Group Diabetologia 2021; doi:10.1007/s00125-021-05436-0

    Author:
    Eleanor McDermid
    Published in:
    Diabetologia 2021; doi:10.1007/s00125-021-05436-0
  • 1

Filter search results

Search Operators:

„ ... ... “ Finds documents with exactly this word group, in exactly this word order and spelling (e.g., "employer branding").
AND Finds documents with both search terms (e.g., sales AND bonus).
OR Finds documents with one or the other search term (e.g., porsche OR volkswagen).
Blank Space Finds documents with all search terms. Blank space is understood as AND (e.g., man robot production).
NOT Finds documents with no appearance of the word behind NOT (e.g., ford NOT "harrison ford").
COUNT(...)>n Finds documents where the search term is mentioned at least "n" times."n" may be any number (e.g., COUNT(gear)>8).
NEAR(..., ..., ) Finds documents with both search terms in any word order, permitting "n" words as a maximum distance between them. Best choose between 15 and 30 (e.g., NEAR(recruit, professionals, 20)).
* Finds documents with the search term in word versions or composites. The star * marks whether you wish them BEFORE, BEHIND, or BEFORE and BEHIND the search term (e.g., lightweight*, *lightweight, *lightweight*).
? Finds documents with the search termn in different spellings."?" allows only one character (e.g., organi?ation).
& + - Special characters are understood as AND (e.g., Miller Bros. & Sons).

You can use operators in your search query to narrow down your results even more.

Tap the operator, or hover the mouse pointer over it, to read more about how it works.